UB Paderborn / Katalog / Suche / in CDI

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Annals of oncology, 2019-07, Vol.30 (7), p.1080-1087

2019

Volltextzugriff (PDF)

Using rADioMIcs and machine learning with ultrasonography for the differential diagnosis of myometRiAL tumors (the ADMIRAL pilot study). Radiomics and differential diagnosis of myometrial tumors

Gynecologic oncology, 2021-06, Vol.161 (3), p.838-844

2021

Volltextzugriff (PDF)

Developing and validating ultrasound‐based radiomics models for predicting high‐risk endometrial cancer

Ultrasound in obstetrics & gynecology, 2022-08, Vol.60 (2), p.256-268

2022

Volltextzugriff (PDF)

Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study

Gynecologic oncology, 2020-10, Vol.159 (1), p.164-170

2020

Volltextzugriff (PDF)

New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection

Gynecologic oncology, 2011-08, Vol.122 (2), p.264-268

2011

Volltextzugriff (PDF)

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer

Annals of oncology, 2024-05, Vol.35 (5), p.414-428

2024

Volltextzugriff (PDF)

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study

European journal of cancer (1990), 2021-01, Vol.143, p.88-100

2021

Volltextzugriff (PDF)

OC03.03: Adnexal masses and risk of malignancy by radiomics: the future is now

Ultrasound in obstetrics & gynecology, 2023-10, Vol.62 (S1), p.7-7

2023

Volltextzugriff (PDF)

EP18.03: Rare solid ovarian metastatic tumours

Ultrasound in obstetrics & gynecology, 2018-10, Vol.52 (S1), p.267-267

2018

Volltextzugriff (PDF)

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Annals of oncology, 2016-03, Vol.27 (3), p.487-493

2016

Volltextzugriff (PDF)

Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study

Gynecologic oncology, 2020-10, Vol.159 (1), p.95-100

2020

Volltextzugriff (PDF)

OP07.10: Artificial intelligence weights the importance of clinical and sonographic factors predicting nodal metastasis in endometrial cancer

Ultrasound in obstetrics & gynecology, 2019-10, Vol.54 (S1), p.107-107

2019

Volltextzugriff (PDF)

OC10.01: Developing and validating ultrasound‐based radiomics models for predicting high‐risk category in endometrial cancer patients

Ultrasound in obstetrics & gynecology, 2021-10, Vol.58 (S1), p.31-31

2021

Volltextzugriff (PDF)

VP66.24: The adoption of radiomics and machine learning improves the diagnostic processes of women with ovarian masses (aroma study)

Ultrasound in obstetrics & gynecology, 2020-10, Vol.56 (S1), p.371-371

2020

Volltextzugriff (PDF)

Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer

European journal of surgical oncology, 2022-12, Vol.48 (12), p.2551-2557

2022

Volltextzugriff (PDF)

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study

Gynecologic oncology, 2019-08, Vol.154 (2), p.323-327

2019

Volltextzugriff (PDF)

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial

Annals of oncology, 2016-08, Vol.27 (8), p.1505-1510

2016

Volltextzugriff (PDF)

The impact of chemotherapy-related leukopenia on survival outcomes in locally advanced cervical cancer

Annals of oncology, 2017-10, Vol.28, p.vi70-vi70

2017

Volltextzugriff (PDF)

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses

Annals of oncology, 2017-10, Vol.28, p.vi70-vi70

2017

Volltextzugriff (PDF)

Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study

European journal of cancer (1990), 2013-03, Vol.49 (5), p.1065-1072

2013

Volltextzugriff (PDF)

OP03.09: Artificial intelligence (AI) weights the importance of factors predicting malignancy at the time of ultrasonographic (US) examination

Ultrasound in obstetrics & gynecology, 2018-10, Vol.52 (S1), p.74-74

2018

Volltextzugriff (PDF)

Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors

Annals of oncology, 2019-07, Vol.30, p.iv125-iv125

2019

Volltextzugriff (PDF)

OP03.02: A score system to assess the risk of ovarian malignancy at ultrasound: predictors and nomogram‐based analyses

Ultrasound in obstetrics & gynecology, 2018-10, Vol.52 (S1), p.72-72

2018

Volltextzugriff (PDF)

P07.01: Artificial intelligence (AI) weights the importance of clinical and sonographic factors predicting malignancy in unilocular‐solid cysts before surgery

Ultrasound in obstetrics & gynecology, 2019-10, Vol.54 (S1), p.173-174

2019

Volltextzugriff (PDF)

Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study

European journal of surgical oncology, 2018-06, Vol.44 (6), p.766-770

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Using rADioMIcs and machine learning with ultrasonography for the differential diagnosis of myometRiAL tumors (the ADMIRAL pilot study). Radiomics and differential diagnosis of myometrial tumors

Developing and validating ultrasound‐based radiomics models for predicting high‐risk endometrial cancer

Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study

New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection

Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study

OC03.03: Adnexal masses and risk of malignancy by radiomics: the future is now

EP18.03: Rare solid ovarian metastatic tumours

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study

OP07.10: Artificial intelligence weights the importance of clinical and sonographic factors predicting nodal metastasis in endometrial cancer

OC10.01: Developing and validating ultrasound‐based radiomics models for predicting high‐risk category in endometrial cancer patients

VP66.24: The adoption of radiomics and machine learning improves the diagnostic processes of women with ovarian masses (aroma study)

Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer

Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial

The impact of chemotherapy-related leukopenia on survival outcomes in locally advanced cervical cancer

Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses

Weekly topotecan and cisplatin (TOPOCIS) as neo-adjuvant chemotherapy for locally-advanced squamous cervical carcinoma: Results of a phase II multicentric study

OP03.09: Artificial intelligence (AI) weights the importance of factors predicting malignancy at the time of ultrasonographic (US) examination

Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors

OP03.02: A score system to assess the risk of ovarian malignancy at ultrasound: predictors and nomogram‐based analyses

P07.01: Artificial intelligence (AI) weights the importance of clinical and sonographic factors predicting malignancy in unilocular‐solid cysts before surgery

Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study

Suchergebnisse filtern